On July 8, 2026, European healthcare networks highlighted the role of parallel distribution directives under the European Medicines Agency (EMA) in securing supply chains for specialty oncology treatments. Sourcing immunotherapies like Opdivo (Nivolumab) 240mg Injection requires navigating strict import guidelines and GDP (Good Distribution Practice) standards.

At Onco Medicine, we operate optimized distribution routes to ensure clinical facilities across Germany and the EU receive original immunotherapies. Temperature control and clinical traceability are the foundations of our distribution logistics.

BfArM Compliance & European Cold-Chain Standards

• German BfArM Compliance: Importing specialty medicines into Germany requires alignment with BfArM regulations, including medical necessity documentation and valid prescriptions.
• GDP Logistics standards: Monoclonal antibodies must be kept strictly between 2°C and 8°C. We pack our shipments in certified thermal containers with integrated sensor logs.
• Express EU Sourcing: Centralized European hubs allow express shipping to hospitals and clinics across Germany and neighboring EU countries within 4 to 7 business days.

Reliable medicine access supports clinical success. By providing complete batch documentation, Certificates of Analysis (COA), and secure logistics, Onco Medicine remains a trusted partner for specialty European clinics.